Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma

Khaenam,Prasong; Jearanaikoon,Patcharee; Pairojkul,Chawalit; Bhudhisawasdi,Vajarabhongsa; Limpaiboon,Temduang

doi:10.3892/etm_00000060

Genetic and epigenetic alterations of RIZ1 and the correlation to clinicopathological parameters in liver fluke-related cholangiocarcinoma

Authors:
- Prasong Khaenam
- Patcharee Jearanaikoon
- Chawalit Pairojkul
- Vajarabhongsa Bhudhisawasdi
- Temduang Limpaiboon
View Affiliations

Affiliations: Department of Biomedical Sciences, Graduate School, Khon Kaen University, Khon Kaen 40002, Thailand
Published online on: March 1, 2010 https://doi.org/10.3892/etm_00000060
Pages: 385-390

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The retinoblastoma interacting zinc finger (RIZ1) gene is adjacent to D1S228 where microsatellite instability has been associated with poor patient survival in liver fluke-associated cholangiocarcinoma (CCA). An understanding of the molecular mechanisms underlying the carcinogenesis and pathogenesis of CCA is necessary to improve patient survival. Therefore, we determined the genetic and epigenetic alterations of RIZ1 in 81 CCA samples and 69 matched non-tumor tissues. Methylation was found in 31 of 81 (38%) tumor samples and in 5 of 69 (7%) matched non-tumor tissues. Frameshift mutations (2 of 81) and loss of heterozygosity (LOH) (14 of 81) were not common. Statistical analysis found no significant correlation between RIZ1 alterations and clinicopathological features, but RIZPro704 LOH was associated with patient survival in the multivariate analysis. RIZ1 hypermethylation may be one of the crucial molecular events contributing to cholangiocarcinogenesis, and RIZPro704 LOH may adversely impact patient survival. The biological function of RIZ1 in CCA should be further investigated in order to verify its potential role in regulating this cancer.

View Figures

View References

1.	Sripa B and Pairojkul C: Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol. 24:349–356. 2008. View Article : Google Scholar : PubMed/NCBI
2.	Sripa B, Kaewkes S, Sithithaworn P, et al: Liver fluke induces cholangiocarcinoma. PLoS Med. 4:e2012007. View Article : Google Scholar : PubMed/NCBI
3.	Limpaiboon T, Tapdara S, Jearanaikoon P, Sripa B and Bhudhisawasdi V: Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma. World J Gastroenterol. 12:4377–4382. 2006.PubMed/NCBI
4.	Buyse IM, Takahashi EI and Huang S: Physical mapping of the retinoblastoma interacting zinc finger gene RIZ to D1S228 on chromosome 1p36. Genomics. 34:119–121. 1996. View Article : Google Scholar : PubMed/NCBI
5.	Liu L, Shao G, Steele-Perkins G and Huang S: The retinoblastoma interacting zinc finger gene RIZ produces a PR domain-lacking product through an internal promoter. J Biol Chem. 272:2984–2991. 1997. View Article : Google Scholar : PubMed/NCBI
6.	Xie M, Shao G, Buyse IM and Huang S: Transcriptional repression mediated by the PR domain zinc finger gene RIZ. J Biol Chem. 272:26360–26366. 1997. View Article : Google Scholar : PubMed/NCBI
7.	Chadwick RB, Jiang GL, Bennington GA, et al: Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA. 97:2662–2667. 2000. View Article : Google Scholar : PubMed/NCBI
8.	Jiang G, Liu L, Buyse IM, Simon D and Huang S: Decreased RIZ1 expression but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer. 83:541–546. 1999. View Article : Google Scholar : PubMed/NCBI
9.	He L, Yu JX, Liu L, et al: RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res. 58:4238–4244. 1998.PubMed/NCBI
10.	Jiang GL and Huang S: Adenovirus expressing RIZ1 in tumor suppressor gene therapy of microsatellite-unstable colorectal cancers. Cancer Res. 61:1796–1798. 2001.PubMed/NCBI
11.	Steele-Perkins G, Fang W, Yang XH, et al: Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev. 15:2250–2262. 2001. View Article : Google Scholar : PubMed/NCBI
12.	Pastural E, Takahashi N, Dong WF, et al: RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia cell lines. Oncogene. 26:1586–1594. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Abbondanza C, Medici N, Nigro V, et al: The retinoblastoma-interacting zinc-finger protein RIZ is a downstream effector of estrogen action. Proc Natl Acad Sci USA. 97:3130–3135. 2000. View Article : Google Scholar : PubMed/NCBI
14.	Carling T, Kim KC, Yang XH, Gu J, Zhang XK and Huang S: A histone methyltransferase is required for maximal response to female sex hormones. Mol Cell Biol. 24:7032–7042. 2004. View Article : Google Scholar : PubMed/NCBI
15.	Gazzerro P, Abbondanza C, D'Arcangelo A, et al: Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation. Exp Cell Res. 312:340–349. 2006.PubMed/NCBI
16.	Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R and Grohe C: Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem. 275:18447–18453. 2000. View Article : Google Scholar : PubMed/NCBI
17.	Tokumaru Y, Nomoto S, Jeronimo C, et al: Biallelic inactivation of the RIZ1 gene in human gastric cancer. Oncogene. 22:6954–6958. 2003. View Article : Google Scholar : PubMed/NCBI
18.	Carling T, Du Y, Fang W, Correa P and Huang S: Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas. Surgery. 134:932–940. 2003. View Article : Google Scholar : PubMed/NCBI
19.	Oshimo Y, Oue N, Mitani Y, et al: Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Int J Cancer. 110:212–218. 2004. View Article : Google Scholar : PubMed/NCBI
20.	Akahira J, Suzuki F, Suzuki T, et al: Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation. Pathol Int. 57:725–733. 2007. View Article : Google Scholar
21.	Poetsch M, Dittberner T and Woenckhaus C: Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36. Oncogene. 21:3038–3042. 2002. View Article : Google Scholar : PubMed/NCBI
22.	Fang W, Piao Z, Simon D, Sheu JC and Huang S: Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13–p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Genes Chromosomes Cancer. 28:269–275. 2000.PubMed/NCBI
23.	Piao Z, Fang W, Malkhosyan S, et al: Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Res. 60:4701–4704. 2000.PubMed/NCBI
24.	Limpaiboon T, Khaenam P, Chinnasri P, et al: Promoter hyper-methylation is a major event in hMLH1 gene inactivation in liver fluke-related cholangiocarcinoma. Cancer Lett. 217:213–219. 2005. View Article : Google Scholar : PubMed/NCBI
25.	Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
26.	Limpaiboon T, Krissadarak K, Sripa B, et al: Microsatellite alterations in liver fluke-related cholangiocarcinoma are associated with poor prognosis. Cancer Lett. 181:215–222. 2002. View Article : Google Scholar : PubMed/NCBI
27.	Yamamoto H, Sawai H and Perucho M: Frameshift somatic mutations in gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res. 57:4420–4426. 1997.PubMed/NCBI
28.	Hasegawa Y, Matsubara A, Teishima J, et al: DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer. Cancer Sci. 98:32–36. 2007. View Article : Google Scholar : PubMed/NCBI
29.	Alvaro D, Barbaro B, Franchitto A, et al: Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. Am J Pathol. 169:877–888. 2006. View Article : Google Scholar : PubMed/NCBI
30.	Grundberg E, Carling T, Brandstrom H, et al: A deletion polymorphism in the RIZ gene, a female sex steroid hormone receptor coactivator, exhibits decreased response to estrogen in vitro and associates with low bone mineral density in young Swedish women. J Clin Endocrinol Metab. 89:6173–6178. 2004. View Article : Google Scholar
31.	Stolk L, van Meurs JB, Arp PP, Hofman A, Pols HA and Uitterlinden AG: The RIZ Pro704 insertion-deletion polymorphism, bone mineral density and fracture risk: the Rotterdam study. Bone. 42:286–293. 2008. View Article : Google Scholar : PubMed/NCBI
32.	Du Y, Carling T, Fang W, Piao Z, Sheu JC and Huang S: Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily. Cancer Res. 61:8094–8099. 2001.PubMed/NCBI